First Turn Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
First Turn Management, LLC
- $558 Billion
- Q4 2024
A detailed history of First Turn Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, First Turn Management, LLC holds 506,908 shares of MIRM stock, worth $26.6 Million. This represents 3.75% of its overall portfolio holdings.
Number of Shares
506,908
Previous 647,611
21.73%
Holding current value
$26.6 Million
Previous $25.3 Billion
17.01%
% of portfolio
3.75%
Previous 4.0%
Shares
5 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$345 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$240 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$170 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$147 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$137 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.93B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...